2012
The burden of cancer in Connecticut.
Gonsalves L, Cartmel B, Mueller L. The burden of cancer in Connecticut. Connecticut Medicine 2012, 76: 335-51. PMID: 22856019.Peer-Reviewed Original Research
2003
Chapter 18 Chemoprevention of Oral Premalignant Lesions
Mayne S, Cartmel B, Morse D. Chapter 18 Chemoprevention of Oral Premalignant Lesions. 2003, 261-269. DOI: 10.1016/b978-012239990-9/50019-9.ChaptersOral precancerous lesionsOral premalignant lesionsPrecancerous lesionsChemoprevention trialsPremalignant lesionsOral premalignancyOral cancer preventionEfficacy of agentsPotential chemopreventive agentsDirect clinical relevancePharyngeal cancerChemoprevention researchChemopreventive efficacySpirulina fusiformisChemopreventive agentsClinical relevanceVitamin ELesionsClinical settingBiological markersSignificant toxicityChemopreventionEfficacySame agentsPrevention
1997
Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.
Levine N, Moon T, Cartmel B, Bangert J, Rodney S, Dong Q, Peng Y, Alberts D. Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group. Cancer Epidemiology Biomarkers & Prevention 1997, 6: 957-61. PMID: 9367070.Peer-Reviewed Original ResearchConceptsCutaneous squamous cell carcinomaSquamous cell carcinomaBasal cell carcinomaNonmelanoma skin cancerCell carcinomaSkin cancerPlacebo-controlled trialHigh-risk subjectsSkin cancer preventionEffect of retinolOral retinolStudy clinicCancer preventionOutcome measuresIsotretinoinBeneficial effectsStudy periodRetinolTrialsCarcinomaCancerPreventionTotal numberParticipantsPlaceboRetinoids in prevention of skin cancer
Moon T, Levine N, Cartmel B, Bangert J. Retinoids in prevention of skin cancer. Cancer Letters 1997, 114: 203-205. PMID: 9103292, DOI: 10.1016/s0304-3835(97)04663-6.Peer-Reviewed Original ResearchConceptsBasal cell skin cancerModerate-risk subjectsPrior skin cancersHigh-risk subjectsRisk subjectsSkin cancerB trialSquamous cell skin cancerSquamous cell cancerEffects of retinoidsActinic keratosesCell cancerClinical trialsIntervention durationCancerTrialsRetinolRetinoidsPlaceboIncidencePreventionSubjectsSignificant benefitsIsotretinoinKeratoses